386 related articles for article (PubMed ID: 20060356)
1. Downregulation of CD9 protein expression is associated with aggressive behavior of oral squamous cell carcinoma.
Buim ME; Lourenço SV; Carvalho KC; Cardim R; Pereira C; Carvalho AL; Fregnani JH; Soares FA
Oral Oncol; 2010 Mar; 46(3):166-71. PubMed ID: 20060356
[TBL] [Abstract][Full Text] [Related]
2. Tetraspanin gene expression levels as potential biomarkers for malignancy of gingival squamous cell carcinoma.
Hirano C; Nagata M; Noman AA; Kitamura N; Ohnishi M; Ohyama T; Kobayashi T; Suzuki K; Yoshizawa M; Izumi N; Fujita H; Takagi R
Int J Cancer; 2009 Jun; 124(12):2911-6. PubMed ID: 19330835
[TBL] [Abstract][Full Text] [Related]
3. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma.
Uchida S; Shimada Y; Watanabe G; Li ZG; Hong T; Miyake M; Imamura M
Br J Cancer; 1999 Mar; 79(7-8):1168-73. PubMed ID: 10098753
[TBL] [Abstract][Full Text] [Related]
4. Expression of tetra-spans transmembrane family (CD9, CD37, CD53, CD63, CD81 and CD82) in normal and neoplastic human keratinocytes: an association of CD9 with alpha 3 beta 1 integrin.
Okochi H; Kato M; Nashiro K; Yoshie O; Miyazono K; Furue M
Br J Dermatol; 1997 Dec; 137(6):856-63. PubMed ID: 9470900
[TBL] [Abstract][Full Text] [Related]
5. Expression of thymidylate synthase and dihydropyrimidine dehydrogenase in primary oral squamous cell carcinoma and corresponding metastases in cervical lymph nodes: association with the metastasis suppressor CD82.
Kawasaki G; Yoshitomi I; Yanamoto S; Yamada S; Mizuno A; Umeda M
Anticancer Res; 2011 Oct; 31(10):3521-6. PubMed ID: 21965773
[TBL] [Abstract][Full Text] [Related]
6. Expression of the tetraspanins CD9, CD37, CD63, and CD151 in Merkel cell carcinoma: strong evidence for a posttranscriptional fine-tuning of CD9 gene expression.
Woegerbauer M; Thurnher D; Houben R; Pammer J; Kloimstein P; Heiduschka G; Petzelbauer P; Erovic BM
Mod Pathol; 2010 May; 23(5):751-62. PubMed ID: 20118909
[TBL] [Abstract][Full Text] [Related]
7. Expression of tetraspanin adaptor proteins below defined threshold values is associated with in vitro invasiveness of mammary carcinoma cells.
Sauer G; Kurzeder C; Grundmann R; Kreienberg R; Zeillinger R; Deissler H
Oncol Rep; 2003; 10(2):405-10. PubMed ID: 12579280
[TBL] [Abstract][Full Text] [Related]
8. CD82, and CD63 in thyroid cancer.
Chen Z; Mustafa T; Trojanowicz B; Brauckhoff M; Gimm O; Schmutzler C; Köhrle J; Holzhausen HJ; Kehlen A; Klonisch T; Finke R; Dralle H; Hoang-Vu C
Int J Mol Med; 2004 Oct; 14(4):517-27. PubMed ID: 15375577
[TBL] [Abstract][Full Text] [Related]
9. Expression of chemokine receptor CCR7 is associated with cervical lymph node metastasis of oral squamous cell carcinoma.
Shang ZJ; Liu K; Shao Z
Oral Oncol; 2009 Jun; 45(6):480-5. PubMed ID: 18752985
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD9 and CD82 in clear cell renal cell carcinoma and its clinical significance.
Kwon HJ; Min SY; Park MJ; Lee C; Park JH; Chae JY; Moon KC
Pathol Res Pract; 2014 May; 210(5):285-90. PubMed ID: 24553302
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of decreased expression of KAI1 metastasis suppressor in human oral carcinogenesis.
Uzawa K; Ono K; Suzuki H; Tanaka C; Yakushiji T; Yamamoto N; Yokoe H; Tanzawa H
Clin Cancer Res; 2002 Mar; 8(3):828-35. PubMed ID: 11895916
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of macrophage inflammatory protein-3α in oral cavity squamous cell carcinoma is associated with nodal metastasis.
Chang KP; Kao HK; Yen TC; Chang YL; Liang Y; Liu SC; Lee LY; Chang YL; Kang CJ; Chen IH; Liao CT; Yu JS
Oral Oncol; 2011 Feb; 47(2):108-13. PubMed ID: 21163685
[TBL] [Abstract][Full Text] [Related]
13. KAI1/CD82 and MRP1/CD9 serve as markers of infiltration, metastasis, and prognosis in laryngeal squamous cell carcinomas.
Zhang BH; Liu W; Li L; Lu JG; Sun YN; Jin DJ; Xu XY
Asian Pac J Cancer Prev; 2013; 14(6):3521-6. PubMed ID: 23886139
[TBL] [Abstract][Full Text] [Related]
14. Expression of KAI1/CD82 and MRP-1/CD9 in transitional cell carcinoma of bladder.
Ai X; Zhang X; Wu Z; Ma X; Ju Z; Wang B; Shi T
J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):79-82. PubMed ID: 17393117
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of KAI1/CD82 protein expression in oral cancer correlates with reduced disease free survival and overall patient survival.
Farhadieh RD; Smee R; Ow K; Yang JL; Russell PJ; Crouch R; Jackson P; Jacobson IV
Cancer Lett; 2004 Sep; 213(1):91-8. PubMed ID: 15312688
[TBL] [Abstract][Full Text] [Related]
16. Expression and prognostic impact of indoleamine 2,3-dioxygenase in oral squamous cell carcinomas.
Laimer K; Troester B; Kloss F; Schafer G; Obrist P; Perathoner A; Laimer J; Brandacher G; Rasse M; Margreiter R; Amberger A
Oral Oncol; 2011 May; 47(5):352-7. PubMed ID: 21440489
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of BST2 is associated with nodal metastasis and poorer prognosis in oral cavity cancer.
Fang KH; Kao HK; Chi LM; Liang Y; Liu SC; Hseuh C; Liao CT; Yen TC; Yu JS; Chang KP
Laryngoscope; 2014 Sep; 124(9):E354-60. PubMed ID: 24706327
[TBL] [Abstract][Full Text] [Related]
18. Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients.
Huang CI; Kohno N; Ogawa E; Adachi M; Taki T; Miyake M
Am J Pathol; 1998 Sep; 153(3):973-83. PubMed ID: 9736046
[TBL] [Abstract][Full Text] [Related]
19. CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins.
Rubinstein E; Le Naour F; Lagaudrière-Gesbert C; Billard M; Conjeaud H; Boucheix C
Eur J Immunol; 1996 Nov; 26(11):2657-65. PubMed ID: 8921952
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and therapeutic relevance of NY-ESO-1 expression in oral squamous cell carcinoma.
Ries J; Mollaoglu N; Vairaktaris E; Neukam FW; Nkenke E
Anticancer Res; 2009 Dec; 29(12):5125-30. PubMed ID: 20044626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]